Citicoline

Form: Oral Tablets/Capsules

Strength: 250 mg, 500 mg, 1000 mg

Reference Brands: Cognizin®(US); Somazina®, NeurAxon®, Ceraxon®(EU)

Category: Antipsychotropic Drugs

Citicoline, a neuroprotective agent, is widely used to enhance cognitive function and support recovery from stroke, traumatic brain injury, and neurodegenerative diseases. Available in oral and injectable forms, Citicoline is marketed in the EU under brands like Somazina and Ceraxon. In the US, it is available primarily as a dietary supplement under the brand Cognizin. Strengths range from 250 mg to 1000 mg for oral use and 100 mg/mL for injections. Citicoline boosts phospholipid synthesis and brain energy metabolism. Pharmacies, hospitals, and B2B pharmaceutical buyers rely on high-quality Citicoline formulations for neurological health support and clinical neurotherapy programs.